• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Susceptibilities of Mycobacterium malmoense determined at the growth optimum pH (pH 6.0).

作者信息

Heginbothom M L, Lindholm-Levy P J, Heifets L B

机构信息

Department of Medical Microbiology and Public Health Laboratory, University Hospital of Wales, Cardiff, UK.

出版信息

Int J Tuberc Lung Dis. 1998 May;2(5):430-4.

PMID:9613641
Abstract

SETTING

Pulmonary disease caused by Mycobacterium malmoense is increasing. Conventional in vitro antimicrobial susceptibilities correlate poorly with response to treatment for this organism. Radiometrically determined minimum inhibitory concentrations (MICs) allow quantitative susceptibility testing for non-tuberculous mycobacteria. The M. avium complex (MAC) has been investigated extensively with this approach, and clear interpretative criteria have been established at pH 6.8. However, there has been little work with the acidophilic M. malmoense, which grows poorly at pH 6.8.

OBJECTIVE

To determine whether MICs at pH 6.0 provide results compatible with the interpretative criteria established for the MAC.

DESIGN

MICs were performed in Middlebrook PZA medium (pH 6.0) and 7H12 medium (pH 6.8) for ten strains of M. malmoense.

RESULTS

MICs can be determined at pH 6.0 for M. malmoense using the criteria adopted for the M. avium complex.

CONCLUSION

The low optimal pH of M. malmoense suits this organism for growth in acid conditions. As with MAC, M. malmoense multiplies within macrophages in vivo, and MICs determined at pH 6.0 may reflect in vivo activity. The combination of radiometric MIC testing at optimal growth pH and interpretation based on pharmacokinetic parameters may be helpful in designing therapeutic regimens.

摘要

相似文献

1
Susceptibilities of Mycobacterium malmoense determined at the growth optimum pH (pH 6.0).
Int J Tuberc Lung Dis. 1998 May;2(5):430-4.
2
The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.机会性分枝杆菌的体外药敏性与其体内治疗反应之间的关系。
Int J Tuberc Lung Dis. 2001 Jun;5(6):539-45.
3
[Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria].[一种新开发的微量稀释试验——肉汤MIC NTM用于测定非结核分枝杆菌抗菌药物最低抑菌浓度的多中心评估]
Rinsho Byori. 2002 Apr;50(4):381-91.
4
[Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].[评估一种新开发的肉汤微量稀释试验方法以确定分枝杆菌抗菌药物的最低抑菌浓度(MICs)]
Rinsho Byori. 1998 Jul;46(7):719-27.
5
Rifabutine minimum inhibitory concentrations (MICs) for non-tuberculous mycobacteria in liquid medium by a radiometric method.采用放射测量法测定利福布汀在液体培养基中对非结核分枝杆菌的最低抑菌浓度(MICs)。
J Chemother. 1989 Jul;1(4 Suppl):218-20.
6
[Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].[使用肉汤微量法检测非结核分枝杆菌的抗分枝杆菌药敏性]
Kekkaku. 2006 Apr;81(4):329-35.
7
[Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].[从体外实验看环丝氨酸治疗非结核分枝杆菌感染的评估]
Kekkaku. 1989 May;64(5):345-9.
8
[MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].左氧氟沙星、克拉霉素和KRM-1648对驻留在MONO-MAC-6人巨噬细胞样细胞和A-549人II型肺泡上皮细胞系中的结核分枝杆菌和鸟分枝杆菌复合体的最低抑菌浓度和最低杀菌浓度
Kekkaku. 1999 Jul;74(7):571-7.
9
In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.采用纸片扩散法对快速生长分枝杆菌进行体外抗菌药敏试验:挪威偶然分枝杆菌和龟分枝杆菌分离株的耐药模式
APMIS. 1993 Jan;101(1):27-32.
10
[In vitro antimicrobial activities of quinolones, rifamycins and macrolides against Mycobacterium tuberculosis and M.avium complex: attempt to establish new assay methods which accurately reflect therapeutic effects of test agents in vivo].喹诺酮类、利福霉素类和大环内酯类药物对结核分枝杆菌和鸟分枝杆菌复合群的体外抗菌活性:尝试建立能准确反映受试药物体内治疗效果的新检测方法
Kekkaku. 1999 Jan;74(1):63-70.

引用本文的文献

1
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.非结核分枝杆菌感染的抗菌药物敏感性试验、耐药机制及治疗。
Clin Microbiol Rev. 2012 Jul;25(3):545-82. doi: 10.1128/CMR.05030-11.